Atossa Therapeutics | 4.20 +0.26 +6.60% | ||
| ATOS | |||
| 高 4.44 | 开 3.92 | 量 94578股 | 总市值 3616.80万 |
| 低 3.91 | 换 1.10% | 额 39.74万 | 市盈TTM 亏损 |
分时
5日
日K
周K
月K
季K
年K
Atossa Therapeutics(ATOS)
02-11 21:55
$Atossa Therapeutics(ATOS)$ 8-K Current report, items 7.01 and 9.01 Accession Number: 0001193125-26-045628 Act: 34 Size: 304 KB 网页链接
Atossa Therapeutics(ATOS)
01-30 21:35
$Atossa Therapeutics(ATOS)$ 4/A [Amend] Statement of changes in beneficial ownership of securities Accession Number: 0001193125-26-030571 Size: 8 KB 网页链接
Atossa Therapeutics(ATOS)
01-26 21:05
$Atossa Therapeutics(ATOS)$ 8-K Current report, items 3.03, 5.03, 5.07, and 9.01 Accession Number: 0001193125-26-021727 Act: 34 Size: 196 KB 网页链接
Atossa Therapeutics(ATOS)
01-23 03:15
$Atossa Therapeutics(ATOS)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001193125-26-019273 Size: 8 KB 网页链接
1赞
Atossa Therapeutics(ATOS)
01-09 21:25
$Atossa Therapeutics(ATOS)$ 8-K Current report, items 2.02, 7.01, and 9.01 Accession Number: 0001193125-26-008314 Act: 34 Size: 8 MB 网页链接
Atossa Therapeutics(ATOS)
01-06 21:35
$Atossa Therapeutics(ATOS)$ 8-K Current report, items 8.01 and 9.01 Accession Number: 0001193125-26-003506 Act: 34 Size: 209 KB 网页链接
Atossa Therapeutics(ATOS)
2025-12-22 21:35
$Atossa Therapeutics(ATOS)$ DEF 14A Other definitive proxy statements Accession Number: 0001193125-25-327630 Act: 34 Size: 2 MB 网页链接
Atossa Therapeutics(ATOS)
2025-12-13 06:05
$Atossa Therapeutics(ATOS)$ PRE 14A Other preliminary proxy statements Accession Number: 0001193125-25-317731 Act: 34 Size: 2 MB 网页链接
Atossa Therapeutics(ATOS)
2025-12-04 21:25
$Atossa Therapeutics(ATOS)$ 8-K Current report, items 8.01 and 9.01 Accession Number: 0001193125-25-307516 Act: 34 Size: 222 KB 网页链接
Atossa Therapeutics(ATOS)
2025-11-12 21:55
$Atossa Therapeutics(ATOS)$ 10-Q Quarterly report [Sections 13 or 15(d)] Accession Number: 0001193125-25-276160 Act: 34 Size: 6 MB 网页链接
Atossa Therapeutics(ATOS)
2025-11-12 21:45
$Atossa Therapeutics(ATOS)$ 8-K Current report, items 2.02 and 9.01 Accession Number: 0001193125-25-276140 Act: 34 Size: 558 KB 网页链接
Atossa Therapeutics(ATOS)
2025-10-22 04:15
$Atossa Therapeutics(ATOS)$ 3 Initial statement of beneficial ownership of securities Accession Number: 0001193125-25-245087 Size: 13 KB 网页链接
Atossa Therapeutics(ATOS)
2025-10-22 04:15
$Atossa Therapeutics(ATOS)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001193125-25-245114 Size: 5 KB 网页链接
Atossa Therapeutics(ATOS)
2025-10-14 19:55
$Atossa Therapeutics(ATOS)$ 8-K Current report, items 5.02 and 7.01 Accession Number: 0001193125-25-238065 Act: 34 Size: 375 KB 网页链接
Atossa Therapeutics(ATOS)
2025-09-27 05:15
$Atossa Therapeutics(ATOS)$ 8-K Current report, item 7.01 Accession Number: 0001193125-25-220788 Act: 34 Size: 12 MB 网页链接
Atossa Therapeutics(ATOS)
2025-09-08 20:45
$Atossa Therapeutics(ATOS)$ 8-K Current report, items 8.01 and 9.01 Accession Number: 0000950170-25-113371 Act: 34 Size: 1 MB 网页链接
Atossa Therapeutics(ATOS)
2025-08-22 04:15
$Atossa Therapeutics(ATOS)$ 8-K Current report, item 3.01 Accession Number: 0000950170-25-110654 Act: 34 Size: 157 KB 网页链接
Atossa Therapeutics(ATOS)
2025-08-12 20:55
$Atossa Therapeutics(ATOS)$ 10-Q Quarterly report [Sections 13 or 15(d)] Accession Number: 0000950170-25-106947 Act: 34 Size: 6 MB 网页链接
Atossa Therapeutics(ATOS)
2025-08-12 20:45
$Atossa Therapeutics(ATOS)$ 8-K Current report, items 2.02 and 9.01 Accession Number: 0000950170-25-106944 Act: 34 Size: 544 KB 网页链接
Atossa Therapeutics(ATOS)
2025-07-29 23:35
$Atossa Therapeutics(ATOS)$ SCHEDULE 13G/A [Amend] Statement of Beneficial Ownership by Certain Investors Accession Number: 0000932471-25-000827 Act: 34 Size: 6 KB 网页链接